92 related articles for article (PubMed ID: 30006154)
1. GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice.
Liu S; Yuan J; Yue W; Bi Y; Shen X; Gao J; Xu X; Lu Z
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3257-3267. PubMed ID: 30006154
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte high-mobility group box 1 protects against steatosis and cellular stress during high fat diet feeding.
Lin M; Long J; Li W; Yang C; Loughran P; O'Doherty R; Billiar TR; Deng M; Scott MJ
Mol Med; 2020 Nov; 26(1):115. PubMed ID: 33238880
[TBL] [Abstract][Full Text] [Related]
3. Preventive effects of caffeine on nicotine plus high-fat diet-induced hepatic steatosis and gain weight: a possible explanation for why obese smokers with high coffee consumption tend to be leaner.
Lu N; Mei X; Li X; Tang X; Yang G; Xiang W
Br J Nutr; 2024 Apr; 131(8):1342-1351. PubMed ID: 38149470
[TBL] [Abstract][Full Text] [Related]
4. Fatty Acid Excess Dysregulates CARF to Initiate the Development of Hepatic Steatosis.
Hasan KM; Parveen M; Pena A; Bautista F; Rivera JC; Huerta RR; Martinez E; Espinoza-Derout J; Sinha-Hikim AP; Friedman TC
Cells; 2023 Apr; 12(7):. PubMed ID: 37048142
[TBL] [Abstract][Full Text] [Related]
5. Fructose induced KHK-C can increase ER stress independent of its effect on lipogenesis to drive liver disease in diet-induced and genetic models of NAFLD.
Park SH; Helsley RN; Fadhul T; Willoughby JLS; Noetzli L; Tu HC; Solheim MH; Fujisaka S; Pan H; Dreyfuss JM; Bons J; Rose J; King CD; Schilling B; Lusis AJ; Pan C; Gupta M; Kulkarni RN; Fitzgerald K; Kern PA; Divanovic S; Kahn CR; Softic S
Metabolism; 2023 Aug; 145():155591. PubMed ID: 37230214
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of ADAR2 ameliorates metabolic-associated fatty liver disease via AMPK signaling pathways in obese mice.
Kung ML; Cheng SM; Wang YH; Cheng KP; Li YL; Hsiao YT; Tan BC; Chen YW
Commun Biol; 2024 May; 7(1):594. PubMed ID: 38760406
[TBL] [Abstract][Full Text] [Related]
7. The critical role of BTRC in hepatic steatosis as an ATGL E3 ligase.
Qi W; Fang Z; Luo C; Hong H; Long Y; Dai Z; Liu J; Zeng Y; Zhou T; Xia Y; Yang X; Gao G
J Mol Cell Biol; 2024 Apr; 15(10):. PubMed ID: 37873692
[TBL] [Abstract][Full Text] [Related]
8. BMAL1 deletion protects against obesity and non-alcoholic fatty liver disease induced by a high-fat diet.
Zhan C; Chen H; Zhang Z; Shao Y; Xu B; Hua R; Yao Q; Liu W; Shen Q
Int J Obes (Lond); 2024 Apr; 48(4):469-476. PubMed ID: 38081925
[TBL] [Abstract][Full Text] [Related]
9. NADPH oxidase 1 promotes hepatic steatosis in obese mice and is abrogated by augmented skeletal muscle mass.
Larion S; Padgett CA; Mintz JD; Thompson JA; Butcher JT; Belin de Chantemèle EJ; Haigh S; Khurana S; Fulton DJ; Stepp DW
Am J Physiol Gastrointest Liver Physiol; 2024 Mar; 326(3):G264-G273. PubMed ID: 38258487
[TBL] [Abstract][Full Text] [Related]
10. Uncaria tomentosa improves insulin sensitivity and inflammation in experimental NAFLD.
Araujo LCC; Feitosa KB; Murata GM; Furigo IC; Teixeira SA; Lucena CF; Ribeiro LM; Muscará MN; Costa SKP; Donato J; Bordin S; Curi R; Carvalho CRO
Sci Rep; 2018 Jul; 8(1):11013. PubMed ID: 30030460
[TBL] [Abstract][Full Text] [Related]
11. The inhibition of inner mitochondrial fusion in hepatocytes reduces non-alcoholic fatty liver and improves metabolic profile during obesity by modulating bile acid conjugation.
Da Dalt L; Moregola A; Svecla M; Pedretti S; Fantini F; Ronzio M; Uboldi P; Dolfini D; Donetti E; Baragetti A; Mitro N; Scorrano L; Norata GD
Cardiovasc Res; 2024 Feb; 119(18):2917-2929. PubMed ID: 37922889
[TBL] [Abstract][Full Text] [Related]
12. Proteomic study of gamma-oryzanol preventive effect on a diet-induced non-alcoholic fatty liver disease model.
Siqueira JS; Garcia JL; Ferron AJT; Moreto F; Sormani LE; Costa MR; Palacio TLN; Nai GA; Aldini G; Francisqueti-Ferron FV; Correa CR; D'Amato A
J Nutr Biochem; 2024 May; 127():109607. PubMed ID: 38432453
[TBL] [Abstract][Full Text] [Related]
13. Increased toxicity and retention of perflourooctane sulfonate (PFOS) in humanized CYP2B6-Transgenic mice compared to Cyp2b-null mice is relieved by a high-fat diet (HFD).
Hamilton MC; Heintz MM; Pfohl M; Marques E; Ford L; Slitt AL; Baldwin WS
Food Chem Toxicol; 2021 Jun; 152():112175. PubMed ID: 33838175
[TBL] [Abstract][Full Text] [Related]
14. Connection of Nicotine to Diet-Induced Obesity and Non-Alcoholic Fatty Liver Disease: Cellular and Mechanistic Insights.
Sinha-Hikim AP; Sinha-Hikim I; Friedman TC
Front Endocrinol (Lausanne); 2017; 8():23. PubMed ID: 28239368
[TBL] [Abstract][Full Text] [Related]
15. Neutral Sphingomyelinase 2 Inhibition Limits Hepatic Steatosis and Inflammation.
Al-Rashed F; Arefanian H; Madhoun AA; Bahman F; Sindhu S; AlSaeed H; Jacob T; Thomas R; Al-Roub A; Alzaid F; Malik MDZ; Nizam R; Thanaraj TA; Al-Mulla F; Hannun YA; Ahmad R
Cells; 2024 Mar; 13(5):. PubMed ID: 38474427
[TBL] [Abstract][Full Text] [Related]
16. Ticagrelor, but Not Clopidogrel, Attenuates Hepatic Steatosis in a Model of Metabolic Dysfunction-Associated Steatotic Liver Disease.
Lee EJ; Lee SM; Oh JH; Kim HY; Saeed WK; Kim HS; Jun DW
Nutrients; 2024 Mar; 16(7):. PubMed ID: 38612954
[TBL] [Abstract][Full Text] [Related]
17. Lipocalin-2 Protects Against Diet-Induced Nonalcoholic Fatty Liver Disease by Targeting Hepatocytes.
Xu Y; Zhu Y; Jadhav K; Li Y; Sun H; Yin L; Kasumov T; Chen X; Zhang Y
Hepatol Commun; 2019 Jun; 3(6):763-775. PubMed ID: 31168511
[TBL] [Abstract][Full Text] [Related]
18. Akt2 deficiency alleviates oxidative stress in the heart and liver via up-regulating SIRT6 during high-fat diet-induced obesity.
Kong W; Peng Y; Ji C; Liu Z; Gao S; Zhang Y; Chen J; Li X; Bao M; Zhang Y; Jiang Q; Wang F; Li Z; Bian X; Ye J
Clin Sci (Lond); 2023 May; 137(10):823-841. PubMed ID: 37184210
[TBL] [Abstract][Full Text] [Related]
19. Genetic Ablation of C/EBPα-p300 Pathway Blocks Development of Obese Pregnancy Associated Liver Disorders in Offspring.
Hanlon MA; Gulati R; Johnston M; Fleifil Y; Rivas M; Timchenko NA
Cell Mol Gastroenterol Hepatol; 2024; 17(3):347-360. PubMed ID: 37967813
[TBL] [Abstract][Full Text] [Related]
20. Alleviation of hepatic insulin resistance and steatosis with NMN via improving endoplasmic reticulum-Mitochondria miscommunication in the liver of HFD mice.
Li Y; Tian X; Yu Q; Bao T; Dai C; Jiang L; Niu K; Yang J; Wang S; Wu X
Biomed Pharmacother; 2024 May; 175():116682. PubMed ID: 38703507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
